Home/SAB Biotherapeutics/Alexander G. Krouse
AG

Alexander G. Krouse

Chief Financial Officer

SAB Biotherapeutics

SAB Biotherapeutics Pipeline

DrugIndicationPhase
SAB-142Type 1 DiabetesPhase 2
SAB-185COVID-19 (SARS-CoV-2)Phase 2/3
SAB-176InfluenzaPhase 1